Stocks
Laboratory Corporation of America Holdings Financial Statements (LH) |
||||||||||
| Laboratory Corporation of America Holdingssmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.02.2022 | 31.12.2022 | 28.02.2023 | 31.12.2023 | 26.02.2024 | 30.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 16 121 | 14 877 | 14 877 | 12 162 | 12 162 | 12 420 | |||
| Operating Income, bln rub | 3 260 | 2 129 | 1 774 | 1 124 | 1 124 | 764.1 | ||||
| EBITDA, bln rub | ? | 4 117 | 2 395 | 2 743 | 1 701 | 1 705 | 1 220 | |||
| Net profit, bln rub | ? | 2 377 | 1 279 | 1 279 | 418.0 | 418.0 | 121.8 | |||
| OCF, bln rub | ? | 3 110 | 1 956 | 1 956 | 1 328 | 1 328 | 1 129 | |||
| CAPEX, bln rub | ? | 460.4 | 481.9 | 481.9 | 453.6 | 453.6 | 466.4 | |||
| FCF, bln rub | ? | 2 649 | 1 474 | 1 474 | 874.1 | 874.1 | 663.0 | |||
| Dividend payout, bln rub | 0.000 | 195.2 | 195.2 | 254.0 | 254.0 | 184.3 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 15.3% | 15.3% | 60.8% | 60.8% | 151.3% | ||||
| OPEX, bln rub | 2 322 | 2 256 | 2 256 | 2 021 | 2 021 | 2 083 | ||||
| Cost of production, bln rub | 10 497 | 10 492 | 10 492 | 9 017 | 9 017 | 9 162 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 2.00 | 2.00 | ||||
| Interest expenses, bln rub | 212.1 | 180.3 | 180.3 | 199.6 | 199.6 | 191.4 | ||||
| Assets, bln rub | 20 385 | 20 155 | 20 155 | 16 725 | 16 725 | 16 531 | ||||
| Net Assets, bln rub | ? | 10 273 | 10 097 | 10 097 | 7 875 | 7 875 | 7 960 | |||
| Debt, bln rub | 6 343 | 6 295 | 6 295 | 5 954 | 5 954 | 5 969 | ||||
| Cash, bln rub | 1 473 | 430.0 | 430.0 | 536.8 | 536.8 | 99.3 | ||||
| Net debt, bln rub | 4 870 | 5 865 | 5 865 | 5 417 | 5 417 | 5 869 | ||||
| Ordinary share price, rub | 269.9 | 235.5 | 202.3 | 227.3 | 227.3 | 199.0 | ||||
| Number of ordinary shares, mln | 96.7 | 91.1 | 91.1 | 87.6 | 87.1 | 84.1 | ||||
| Market cap, bln rub | 26 102 | 21 452 | 18 429 | 19 911 | 19 797 | 16 733 | ||||
| EV, bln rub | ? | 30 972 | 27 317 | 24 294 | 25 328 | 25 214 | 22 603 | |||
| Book value, bln rub | -1 422 | -1 971 | -1 971 | -1 610 | -1 610 | -1 653 | ||||
| EPS, rub | ? | 24.6 | 14.0 | 14.0 | 4.77 | 4.80 | 1.45 | |||
| FCF/share, rub | 27.4 | 16.2 | 16.2 | 9.98 | 10.0 | 7.88 | ||||
| BV/share, rub | -14.7 | -21.6 | -21.6 | -18.4 | -18.5 | -19.7 | ||||
| EBITDA margin, % | ? | 25.5% | 16.1% | 18.4% | 14.0% | 14.0% | 9.82% | |||
| Net margin, % | ? | 14.7% | 8.60% | 8.60% | 3.44% | 3.44% | 0.98% | |||
| FCF yield, % | ? | 10.1% | 6.87% | 8.00% | 4.39% | 4.42% | 3.96% | |||
| ROE, % | ? | 23.1% | 12.7% | 12.7% | 5.31% | 5.31% | 1.53% | |||
| ROA, % | ? | 11.7% | 6.35% | 6.35% | 2.50% | 2.50% | 0.74% | |||
| P/E | ? | 11.0 | 16.8 | 14.4 | 47.6 | 47.4 | 137.4 | |||
| P/FCF | 9.85 | 14.6 | 12.5 | 22.8 | 22.6 | 25.2 | ||||
| P/S | ? | 1.62 | 1.44 | 1.24 | 1.64 | 1.63 | 1.35 | |||
| P/BV | ? | -18.4 | -10.9 | -9.35 | -12.4 | -12.3 | -10.1 | |||
| EV/EBITDA | ? | 7.52 | 11.4 | 8.86 | 14.9 | 14.8 | 18.5 | |||
| Debt/EBITDA | 1.18 | 2.45 | 2.14 | 3.18 | 3.18 | 4.81 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.44% | 0.43% | ||||
| CAPEX/Revenue, % | 2.86% | 3.24% | 3.24% | 3.73% | 3.73% | 3.76% | ||||
| Laboratory Corporation of America Holdings shareholders | ||||||||||
